Literature DB >> 25927154

Conjunctival myxoma: a synopsis of a rare ocular tumor.

Meng-Jun Xiong1, Daniel C Dim.   

Abstract

Conjunctival myxoma is an exceptionally rare, slow-growing, benign neoplasm of primitive mesenchyme origin. Forty-one cases of conjunctival myxoma from a literature review, including the authors' case, are listed. The usual clinical history is a painless mass appearing during months to years. Grossly, the tumor is a well-circumscribed, cystlike, gelatinous, yellow-to-pink, translucent-to-solid mass. Microscopically, the hypocellular tumor contains stellate- and spindle-shaped cells in a mucoid stroma with abundant hyaluronic acid mucopolysaccharides. Vimentin and α-smooth muscle actin highlight the spindle and stellate cells. S100 protein and desmin are negative for the tumor cells. Treatment is complete surgical excision, with no recurrence reported in the follow-up period. Notably, conjunctival myxoma may be associated with Carney complex, an autosomal-dominant disorder associated with skin pigmentation, endocrine abnormalities, and myxoma of the heart and eye. Physicians should appreciate this unique ocular tumor because of its potential association with Carney complex.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25927154     DOI: 10.5858/arpa.2013-0532-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Clinical appearance and pathological findings of conjunctival myxoma: Case report and literature review.

Authors:  Kuo-Hsuan Hung; Lung-Kun Yeh
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-05

2.  Conjunctival myxoma masquerading as conjunctival lymphoma: A case report.

Authors:  Majed Alkharashi; Hind M Alkatan; Ahmed A Alhumidi; Wael Otaif
Journal:  Int J Surg Case Rep       Date:  2022-07-21

3.  Lacrimal gland myxoma.

Authors:  Drushti Parikh; Bipasha Mukherjee
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.